Amgen Inc.
AMGN
$296.47
$6.182.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 33.51B | 32.78B | 32.03B | 31.14B | 29.54B |
| Total Other Revenue | 1.41B | 1.35B | 1.40B | 1.39B | 1.39B |
| Total Revenue | 34.92B | 34.13B | 33.42B | 32.53B | 30.93B |
| Cost of Revenue | 9.30B | 9.20B | 9.11B | 10.85B | 9.35B |
| Gross Profit | 25.62B | 24.92B | 24.32B | 21.69B | 21.59B |
| SG&A Expenses | 6.88B | 6.98B | 7.10B | 7.01B | 6.73B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 236.00M | 170.00M | 177.00M | -666.00M | 61.00M |
| Total Operating Expenses | 22.82B | 22.46B | 22.34B | 22.96B | 21.54B |
| Operating Income | 12.10B | 11.67B | 11.08B | 9.57B | 9.39B |
| Income Before Tax | 7.42B | 6.65B | 4.61B | 4.68B | 3.53B |
| Income Tax Expenses | 805.00M | 717.00M | 519.00M | 449.00M | 395.00M |
| Earnings from Continuing Operations | 6.62K | 5.93K | 4.09K | 4.23K | 3.13K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.62B | 5.93B | 4.09B | 4.23B | 3.13B |
| EBIT | 12.10B | 11.67B | 11.08B | 9.57B | 9.39B |
| EBITDA | 17.51B | 17.14B | 16.56B | 15.01B | 14.33B |
| EPS Basic | 12.31 | 11.04 | 7.62 | 7.88 | 5.85 |
| Normalized Basic EPS | 10.10 | 9.94 | 9.33 | 7.19 | 7.46 |
| EPS Diluted | 12.23 | 10.96 | 7.55 | 7.81 | 5.81 |
| Normalized Diluted EPS | 10.02 | 9.86 | 9.25 | 7.13 | 7.41 |
| Average Basic Shares Outstanding | 2.15B | 2.15B | 2.15B | 2.15B | 2.14B |
| Average Diluted Shares Outstanding | 2.17B | 2.17B | 2.16B | 2.16B | 2.16B |
| Dividend Per Share | 9.26 | 9.13 | 9.00 | 8.88 | 8.76 |
| Payout Ratio | 75.15% | 82.64% | 118.14% | 112.70% | 150.06% |